Autolus Therapeutics plc (AUTL) Q1 2025 Earnings Call Transcript

2025-05-11 04:22:50 ET

Autolus Therapeutics plc (AUTL)

Q1 2025 Earnings Conference Call

May 8, 2025 8:30 AM ET

Company Participants

Amanda Cray – Executive Director-Investor Relations

Christian Itin – Chief Executive Officer

Rob Dolski – Chief Financial Officer

Conference Call Participants

James Shin – Deutsche Bank

Matthew Phipps – William Blair

Karina Rabayeva – Truist

Gil Blum – Needham & Company

Yanan Zhu – Wells Fargo

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Autolus First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, Amanda Cray, Executive Director of Investor Relations. Please go ahead.

Amanda Cray

Good morning or good afternoon, everyone, and thank you for joining us on today’s call. With me are Chief Executive Officer, Dr. Christian Itin; and Chief Financial Officer, Rob Dolski. I’d like to remind you that during today’s call, we will make statements related to our business that are forward-looking under federal securities laws and the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

These may include, but are not limited to, statements regarding status of the ongoing commercial launch of AUCATZYL in the U.S., Autolus’ manufacturing, sales and marketing plans for AUCATZYL, the market potential for AUCATZYL and the status of clinical trials, development and/or regulatory timelines and market opportunities for obe-cel and our other product candidates.

These statements are subject to a variety of risks and uncertainties that could cause actual results to differ materially from expectations and reflect our views only as of today. We assume no obligation to update any such forward-looking statements. For a discussion of the material risks and uncertainties that could affect our actual results, please refer to the risks identified in today’s press release and in our SEC filings, both available on the Investors section of our website.

Turning to Slide 3, you’ll see the agenda for today’s call. As usual, Christian will provide an overview of our operational highlights. Rob will then discuss the financial results, and Christian will conclude with upcoming milestones and closing remarks. We’ll then take questions....

Read the full article on Seeking Alpha

For further details see: